GEC-ESTRO/ACROP recommendations for quality assurance of ultrasound imaging in brachytherapy. (July 2020)
- Record Type:
- Journal Article
- Title:
- GEC-ESTRO/ACROP recommendations for quality assurance of ultrasound imaging in brachytherapy. (July 2020)
- Main Title:
- GEC-ESTRO/ACROP recommendations for quality assurance of ultrasound imaging in brachytherapy
- Authors:
- Siebert, Frank-André
Kirisits, Christian
Hellebust, Taran Paulsen
Baltas, Dimos
Verhaegen, Frank
Camps, Saskia
Pieters, Bradley
Kovács, György
Thomadsen, Bruce - Abstract:
- Highlights: Ultrasound (US) quality assurance (QA) is very important to achieving consistent, high quality, image-guided implants. Ultrasound unit QA consists mostly periodic QA for the US imaging system and for the needle alignment devices. Evaluation of the US imaging capabilities requires a phantom with tests objects that show the limits of the quantity tested. Much of the alignment testing can be performed in a water tank. Abstract: Ultrasound (US) is an important imaging modality in brachytherapy (BT). In particular for low-dose-rate (LDR) and high-dose-rate (HDR) prostate implants transrectal ultrasound (TRUS) is widespread. Besides the common use of US for prostate implants, US can also be applied in gynecological and anal cancer therapies as examples amongst others. The BRAPHYQS (BRAchytherapy PHYsics Quality assurance System) and UroGEC (urology) working groups of GEC-ESTRO (GEC: Groupe Européen de Curiethérapie, committee of ESTRO: European SocieTy for Radiotherapy & Oncology) elaborated upon guidelines describing quality assurance (QA) methods for US in BT. The total quality management (QM) for the unit includes acceptance testing, commissioning and periodic image testing. In 2008, the AAPM (American Association of Physicists in Medicine) published the TG (Task group) 128 report. Whereas the TG 128 focuses on US systems and prostate BT, the current recommendations also cover tests for stepping devices and include other interstitial or intracavitary treatment sitesHighlights: Ultrasound (US) quality assurance (QA) is very important to achieving consistent, high quality, image-guided implants. Ultrasound unit QA consists mostly periodic QA for the US imaging system and for the needle alignment devices. Evaluation of the US imaging capabilities requires a phantom with tests objects that show the limits of the quantity tested. Much of the alignment testing can be performed in a water tank. Abstract: Ultrasound (US) is an important imaging modality in brachytherapy (BT). In particular for low-dose-rate (LDR) and high-dose-rate (HDR) prostate implants transrectal ultrasound (TRUS) is widespread. Besides the common use of US for prostate implants, US can also be applied in gynecological and anal cancer therapies as examples amongst others. The BRAPHYQS (BRAchytherapy PHYsics Quality assurance System) and UroGEC (urology) working groups of GEC-ESTRO (GEC: Groupe Européen de Curiethérapie, committee of ESTRO: European SocieTy for Radiotherapy & Oncology) elaborated upon guidelines describing quality assurance (QA) methods for US in BT. The total quality management (QM) for the unit includes acceptance testing, commissioning and periodic image testing. In 2008, the AAPM (American Association of Physicists in Medicine) published the TG (Task group) 128 report. Whereas the TG 128 focuses on US systems and prostate BT, the current recommendations also cover tests for stepping devices and include other interstitial or intracavitary treatment sites in BT, such as anal implants and gynecological BT. The recommendations presented herein do not replace regular maintenance for the US devices performed by the vendor. They are the QA of US in BT but are not sufficient for the whole maintenance of medical US devices. Moreover, national regulations and recommendations should also be followed. For the tests presented in this report tolerances or action limits are given. These recommendations explain practical test procedures of US devices in BT. They will help the clinics to perform a high level of quality in the use of US for BT in Europe. … (more)
- Is Part Of:
- Radiotherapy and oncology. Volume 148(2020)
- Journal:
- Radiotherapy and oncology
- Issue:
- Volume 148(2020)
- Issue Display:
- Volume 148, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 148
- Issue:
- 2020
- Issue Sort Value:
- 2020-0148-2020-0000
- Page Start:
- 51
- Page End:
- 56
- Publication Date:
- 2020-07
- Subjects:
- Ultrasound -- Brachytherapy -- Quality assurance -- Stepping device
Oncology -- Periodicals
Radiotherapy -- Periodicals
Tumors -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- radiotherapy -- Periodicals
Radiotherapy -- Periodicals
Radiothérapie -- Périodiques
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9940642 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01678140 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01678140 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01678140 ↗
http://www.estro.org/ ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/radiotherapy-and-oncology/ ↗ - DOI:
- 10.1016/j.radonc.2020.02.024 ↗
- Languages:
- English
- ISSNs:
- 0167-8140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7240.790000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13567.xml